The impact of CytoGam on cardiac transplant recipients with moderate hypogammaglobulinemia: A randomized single-center study

Journal of Heart and Lung Transplantation

Volumn 24, Issue 11, 2005, Pages 1766-1769

  Yamani, Mohamad H ^a,b   Avery, Robin ^a   Mawhorter, Steven D ^a   McNeill, Ann ^a   Cook, Daniel ^a   Ratliff, Norman B ^a   Pelegrin, David ^a   Colosimo, Phyllis ^a   Kiefer, Karen ^a   Ludrosky, Kristin ^a   Hobbs, Robert ^a   Taylor, David ^a   Buda, Tiffany ^a   Yeager, Michael ^a   Young, James B ^a   Smedira, Nicholas ^a   Starling, Randall C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Department of Cardiology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CYCLOSPORIN A; CYTOMEGALOVIRUS ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; VALGANCICLOVIR;

ADULT; ARTICLE; CARDIAC GRAFT REJECTION; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEART GRAFT; HEART TRANSPLANTATION; HUMAN; HYPOGAMMAGLOBULINEMIA; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGAMMAGLOBULINEMIA; CARDIOMYOPATHY, DILATED; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULINS; MALE;

EID: 27844535390     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2004.11.016     Document Type: Article

References (7)

1. D.P. Kontoyiannis, R.H. Rubin Infection in the organ transplant recipient Infect Dis Clin North Am 9 1995 811 822
2. R. Corales, J. Chua, S. Mawhorter Significant hypogammaglobulinemia in six heart transplant recipients an emerging clinical phenomenon? Transplant Infect Dis 2 2000 133 139
3. N.S. Goldfarb, R.K. Avery, M. Goormastic Hypogammaglobulinemia in lung transplant recipients Transplantation 71 2001 242 246
4. M.H. Yamani, R.K. Avery, S. Mawhorter Hypogammaglobulinemia following cardiac transplantation a link between rejection and infection J Heart Lung Transplant 20 2001 425 431
5. M.H. Yamani, R. Avery, S. Mawhorter Hypogammaglobulinemia after heart transplantation impact of pre-emptive use of immunoglobulin replacement (CytoGam) on infection and rejection outcomes Transplant Infectious Disease 3 2001 40 43
6. R.M. Kruger, S. Paranjothi, G.A. Storch, J.P. Lynch, E.P. Trulock Impact of prophylaxis with cytogam alone on the incidence of CMV viremia in CMV-seropositive lung transplant recipients J Heart Lung Transplant 22 2003 754 763
7. A.A. Kocher, N. Bonaros, D. Dunkler Long-term results of CMV hyperimmune globulin prophylaxis in 377 heart transplant recipients J Heart Lung Transplant 22 2003 250 257